GSK FDA calendar & decision history GSK plc · 1 upcoming · 10 past FDA decisions
Upcoming FDA catalysts GSK · Oct 26, 2026 FDA decision FDA decision history (10) Jun 17, 2026✓ Approved Utebzi (Tebipenem HBr) - (PIVO Mar 19, 2026✓ Approved Linerixibat - (GLISTEN) Mar 13, 2026✓ Approved Arexvy Dec 11, 2025✓ Approved FDA decision Oct 23, 2025✓ Approved FDA decision Jul 17, 2025✓ Approved FDA decision Jun 24, 2025✓ Approved FDA decision May 22, 2025✓ Approved FDA decision Mar 25, 2025✓ Approved FDA decision Feb 17, 2025✓ Approved FDA decision See the full 2026 PDUFA calendar → This page aggregates GSK's FDA catalysts from pdufa.bio's own calendar and decision archive. Each item links to its source page. Facts and dates only; verify against primary FDA / SEC / company filings.
Not affiliated with or endorsed by the FDA. pdufa.bio is an independent service; "FDA", "PDUFA", and all company, drug, and ticker names are used descriptively and remain the property of their owners. Informational and educational only — not investment advice. Data and historical statistics only; no trade recommendations and no individual-drug approval probabilities. Verify every date and outcome against primary FDA / SEC / company filings. © 2026 pdufa.bio